FI68222C - Foerfarande foer 0-metylering av hydroxiaporfiner - Google Patents
Foerfarande foer 0-metylering av hydroxiaporfiner Download PDFInfo
- Publication number
- FI68222C FI68222C FI783951A FI783951A FI68222C FI 68222 C FI68222 C FI 68222C FI 783951 A FI783951 A FI 783951A FI 783951 A FI783951 A FI 783951A FI 68222 C FI68222 C FI 68222C
- Authority
- FI
- Finland
- Prior art keywords
- methylation
- hydroxy
- och3
- reaction
- methylated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Claims (9)
1 H 'ry'" r7 R6 där minst en av symbolerna - R„ är en hydroxylgrupp och de andra symbolerna är väteatomer eller substituente vilka är inerta under reaktionsbetingelserna, som används, och Rg är en lägre al-kylgrupp, O-metyleras i ett inert lösningsmedel med en förening med formeln CH3 _ j1—- CH3 · X ® II ^ CH3 där X® är en hydroxylgrupp eller en lägre alkoxigrupp, varefter reaktionsprodukten isoleras och, om sä önskas, omvandlas tili ett farmakologiskt godtagbart sait.
1. Förfarande för O-metylering av hydroxiaporfiner, k ä n-netecknat därav, att de fenoliska hydroxylgrupperna i en förening raed formeln fl H\^H H H
2. Förfarande enligt patentkravet l,kännetecknat därav, att alkyleringsmedlet, som används, är fenvltrimetylammonium-metylat eller fenyltrimetylammoniumetylat.
3. Förfarande enligt patentkravet 1 eller 2, känneteck--n a t därav, att O-metyleringen utförs vid en temperatur av 100 - 15 0°C.
4. Förfarande enligt patentkravet 3,kännetecknat därav, att O-metyleringen utförs vid en temperatur av 110 - 135°C.
5. Förfarande enligt nägot av fcregäende patentkrav, k ä n-netecknat därav, att lösningsmedlet, som används, är en blandning av ett kolväte och ett polärt lösningsmedel. li
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2757335 | 1977-12-22 | ||
DE2757335A DE2757335C3 (de) | 1977-12-22 | 1977-12-22 | Verfahren zur O-Methylierung von Hydroxyaporphinen |
Publications (3)
Publication Number | Publication Date |
---|---|
FI783951A FI783951A (fi) | 1979-06-23 |
FI68222B FI68222B (fi) | 1985-04-30 |
FI68222C true FI68222C (fi) | 1985-08-12 |
Family
ID=6026924
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI783951A FI68222C (fi) | 1977-12-22 | 1978-12-21 | Foerfarande foer 0-metylering av hydroxiaporfiner |
Country Status (14)
Country | Link |
---|---|
US (1) | US4309542A (sv) |
JP (1) | JPS54119474A (sv) |
AT (1) | AT362535B (sv) |
BE (1) | BE872843A (sv) |
CH (1) | CH645629A5 (sv) |
CS (1) | CS238601B2 (sv) |
DD (1) | DD141830A5 (sv) |
DE (1) | DE2757335C3 (sv) |
FI (1) | FI68222C (sv) |
FR (1) | FR2430942A1 (sv) |
GB (1) | GB2010841B (sv) |
HU (1) | HU177060B (sv) |
NL (1) | NL7812394A (sv) |
SU (1) | SU925249A3 (sv) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3118521A1 (de) * | 1981-05-09 | 1982-12-02 | Gödecke AG, 1000 Berlin | Dibenzo(de,g)chinolin-derivate, verfahren zu deren herstellung und deren verwendung bei der bekaempfung von erkaeltungskrankheiten und allergien |
US4795759A (en) * | 1985-07-27 | 1989-01-03 | Sandoz Ltd. | Use of dibenz(CD,F)indoles |
US6210680B1 (en) | 1999-06-11 | 2001-04-03 | Univera Pharmaceuticals, Inc. | Method for the prevention and treatment of chronic venous insufficiency |
TWI225397B (en) * | 2000-05-04 | 2004-12-21 | Nat Science Council | Uses of thaliporphine or its derivatives in treatment of cardiac diseases and preparation of the same |
KR100522008B1 (ko) * | 2000-08-23 | 2005-10-18 | 로터스 파마세티컬 리미티드 컴퍼니 | 심장병 치료 및 예방에 있어서의 탈리포르핀 또는 그유도체의 용도 |
JP2006527699A (ja) * | 2003-06-19 | 2006-12-07 | 美時化学製薬股▲ふん▼有限公司 | アポルフィン、及び、ケトンアポルフィン化合物とその用途 |
CN1884265A (zh) * | 2005-06-20 | 2006-12-27 | 美时化学制药股份有限公司 | 治疗糖尿病的阿朴芬及次阿朴芬化合物 |
WO2007134485A1 (en) * | 2006-05-22 | 2007-11-29 | Lotus Pharmaceutical Co., Ltd. | Aporphine and oxoaporphine compounds and pharmaceutical use thereof |
TWI531369B (zh) * | 2014-05-30 | 2016-05-01 | 資元堂生物科技股份有限公司 | 阿朴啡生物鹼衍生物用於製備促進ampk活性的藥物之用途 |
CN111196801B (zh) * | 2020-01-14 | 2022-10-14 | 中国药科大学 | 阿朴菲类生物碱衍生物及其制备方法与用途 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1100998A (en) * | 1912-05-06 | 1914-06-23 | Firm Of Mckesson & Robbins | Process of manufacuring alkyl-ethers of morphin. |
GB1364318A (en) * | 1971-03-15 | 1974-08-21 | Bellon Labor Sa Roger | Laurotetanine derivatives |
DE2337507A1 (de) * | 1973-07-24 | 1975-02-13 | Research Corp | Verfahren zur herstellung von aporphinen ueber neue zwischenprodukte |
DE2625116C2 (de) * | 1976-06-04 | 1984-01-26 | Gödecke AG, 1000 Berlin | Verfahren zur Herstellung von 4-Hydroxy-aporphin-Derivaten |
-
1977
- 1977-12-22 DE DE2757335A patent/DE2757335C3/de not_active Expired
-
1978
- 1978-12-14 FR FR7835193A patent/FR2430942A1/fr active Granted
- 1978-12-18 BE BE192382A patent/BE872843A/xx not_active IP Right Cessation
- 1978-12-19 US US05/971,143 patent/US4309542A/en not_active Expired - Lifetime
- 1978-12-19 GB GB7849004A patent/GB2010841B/en not_active Expired
- 1978-12-20 DD DD78209943A patent/DD141830A5/de unknown
- 1978-12-21 SU SU782700555A patent/SU925249A3/ru active
- 1978-12-21 NL NL7812394A patent/NL7812394A/xx not_active Application Discontinuation
- 1978-12-21 JP JP15695578A patent/JPS54119474A/ja active Pending
- 1978-12-21 AT AT913578A patent/AT362535B/de not_active IP Right Cessation
- 1978-12-21 FI FI783951A patent/FI68222C/fi not_active IP Right Cessation
- 1978-12-21 HU HU78WA355A patent/HU177060B/hu unknown
- 1978-12-21 CH CH1305678A patent/CH645629A5/de not_active IP Right Cessation
- 1978-12-22 CS CS788857A patent/CS238601B2/cs unknown
Also Published As
Publication number | Publication date |
---|---|
CH645629A5 (de) | 1984-10-15 |
BE872843A (fr) | 1979-04-17 |
DE2757335B2 (de) | 1981-05-27 |
FR2430942B1 (sv) | 1985-02-22 |
ATA913578A (de) | 1980-10-15 |
DE2757335C3 (de) | 1982-03-25 |
DE2757335A1 (de) | 1979-06-28 |
JPS54119474A (en) | 1979-09-17 |
FR2430942A1 (fr) | 1980-02-08 |
SU925249A3 (ru) | 1982-04-30 |
NL7812394A (nl) | 1979-06-26 |
GB2010841A (en) | 1979-07-04 |
FI68222B (fi) | 1985-04-30 |
AT362535B (de) | 1981-05-25 |
DD141830A5 (de) | 1980-05-21 |
FI783951A (fi) | 1979-06-23 |
GB2010841B (en) | 1982-08-18 |
HU177060B (hu) | 1981-06-28 |
CS238601B2 (en) | 1985-12-16 |
US4309542A (en) | 1982-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI68222C (fi) | Foerfarande foer 0-metylering av hydroxiaporfiner | |
Kupchan et al. | Photochemical synthesis of aporphines | |
HU185133B (en) | Process for producing 1-hydroxy-octahydro-benzo-bracket-c-bracket closed-quinolines and derivatives | |
AU2012200439B2 (en) | New Process for the Synthesis of Ivabradine and Addition Salts thereof with a Pharmaceutically Acceptable Acid | |
FR2485537A2 (fr) | Dipyrido(4,3-b)(3,4-f)indoles, procede d'obtention, application therapeutique et compositions pharmaceutiques les contenant | |
Moody et al. | Vinyl azides in heterocyclic synthesis. Part 10. Synthesis of the isoindolobenzazepine alkaloid lennoxamine | |
JP2011513197A (ja) | ポリヒドロキシスチルベン化合物の合成方法 | |
HU227558B1 (en) | 4-substituted piperidine derivatives and pharmaceutical compositions containing them | |
US3726924A (en) | Method for the preparation of tris (dimethylamino) methane | |
JP2009173672A (ja) | 化合物の求核置換反応における使用 | |
KR101625128B1 (ko) | 3,4-디메톡시바이사이클로[4.2.0]옥타-1,3,5-트리엔-7-카보니트릴의 합성 방법, 및 이바브라딘 및 이의 약제학적으로 허용되는 산과의 부가염의 합성에서의 적용 | |
KR101637177B1 (ko) | 8-히드록시클로미프라민 또는 이의 약학적으로 허용가능한 염의 제조방법 | |
FR2997696A1 (fr) | Nouveau procede de synthese du (2e)-3-(3,4-dimethoxyphenyl)prop-2-enenitrile, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable | |
FI79100B (fi) | Isokinolinderivat och foerfarande foer framstaellning daerav. | |
US3453283A (en) | Novel 6-substituted-1-(piperidyl-alkyl)-1,2,3,4-tetrahydronaphthalenes | |
ITOH et al. | The Syntheses and β-Adrenoceptor Activities of N-Substituted 2-Amino-5, 6-dihydroxy-1, 2, 3, 4-tetrahydro-1-naphthalenols | |
Heaney et al. | The synthesis of 2-arylmethyltetrahydroisoquinolines from bis (aminol) ethers involving two iminium salt intermediates | |
AU2013257530A1 (en) | New process for the Synthesis of 3-(2-Bromo-4,5-dimethoxyphenyl)propanenitrile, and Application in the Synthesis of Ivabradine and Addition Salts Thereof With a Pharmaceutically Acceptable Acid | |
Gao et al. | Regioselective assembly of 3, 4-dihydroisoquinoline derivatives | |
Gan et al. | An improved synthesis of substituted indan-1-carboxylic acid | |
KR100932071B1 (ko) | 벤잘아세토페논 유도체의 제조방법 | |
US4301290A (en) | Organic compounds | |
Ahmad et al. | Aryne Formation from 2-Bromolaudanosine. Fate of the 5, 6, 12, 12a-Tetrahydrodibenzo [b, g] indolizinium Ion and an Alternative Synthesis of Glaucine | |
KR101620158B1 (ko) | 1-알킬-2-페닐-4-퀴놀론의 제조방법 | |
US4376860A (en) | Pyridyl ketone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM | Patent lapsed |
Owner name: WARNER-LAMBERT COMPANY |